Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

TIDACT CAPSULE 150 mg

Approval Number

SIN10164P

Drug Name

TIDACT CAPSULE 150 mg

Product Name

TIDACT CAPSULE 150 mg

Approval Date

October 5, 1998

Registrant

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Licence Holder

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Regulatory Information

Registrant

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Licence Holder

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

J01FF01

ATC Item Name

clindamycin

Manufacturer Information

Pharmaceutical Manufacturer

YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD

Manufacturers

Y S P INDUSTRIES (M) SDN BHD

Active Ingredients

Ingredient Name

CLINDAMYCIN HCl EQV CLINDAMYCIN

Strength

150 mg

Drug MonographClindamycin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

TIDACT CAPSULE 150 mg - HSA Approval | MedPath